Volume 5, Issue 6
Appendicesp. 838
Author index: Volume 5 Issue 6
Clinical Trial Teportp. 829
Zoledronic acid in the management of osteoporosis: the HORIZON trials
Author(s): E Michael Lewiecki
Drug Evaluationp. 817
Desloratadine: a review of pharmacology and clinical efficacy in allergic rhinitis and urticaria
Author(s): Evrim Alyamac Dizdar, Bulent Enis Sekerel and Ayfer Tuncer
Drug Evaluationp. 807
Ranolazine extended-release for chronic angina
Author(s): Laura M Gruen and Carl J Pepine
Editorialp. 797
Current perspectives for the use of corticosteroids in sepsis: patient selection is the key
Author(s): Jorge IF Salluh, Pedro Povoa, Fernando A Bozza, Marcio Soares and PatrÃÂcia T Bozza
Editorialp. 793
The search for new anticoagulants: dabigatran etexilate
Author(s): Aurangzeb Siddique, Eduard Shantsila and Gregory YH Lip
Appendicesp. 844
Author guidelines: Volume 5 Issue 6
Appendicesp. 843
Acknowledgement: Volume 5 Issue 6
Appendicesp. 839
Compound Index: Volume 5 Issue 6
Forewordp. 727
Looking backwards and moving forwards in the therapy of hypertension
Author(s): Robert J MacFadyen
Appendicesp. 837
Glossary: Volume 5 Issue 6
Special Reportp. 787
Secondary hypertension: etiology and mechanism of disease
Author(s): Jeffrey H Freihage, Aravinda Nanjundappa and Robert S Dieter
Review Articlep. 779
Weight-reducing drug therapy and hypertension
Author(s): Julia Schimkus and Jurgen Scholze
Review Articlep. 773
Continuing evolution of the role of �?²-blockers in the treatment of hypertension
Author(s): Thomas D Giles
Drug Evaluationp. 751
Clevidipine and the management of acute hypertension
Author(s): Joseph Varon and Jorge E Angeles
Drug Evaluationp. 739
Inhibition of endothelin-1 with darusentan: a novel antihypertensive approach for the treatment of resistant hypertension
Author(s): Robert Weiss, Christopher A Graybill, Jennifer Linseman & Marshelle Warren
News and Viewsp. 731
